Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...

Rocket Lab Corporation stock stays volatile after a Neutron setback delays launch. Click here for this updated look at RKLB ...

Mars Sample Return would have turbo-charged Rocket Lab's revenue and added a feather to its cap.

Danaher (NYSE:DHR) has entered an investment partnership with Automata, an AI ready lab automation company. The collaboration ...

ABT, is repositioning its business after ongoing challenges in its Nutrition segment. The company is advancing a major acquisition of Exact Sciences to expand into oncology diagnostics. Management is ...

British Land’s offer values each Life Science REIT share at approximately 42.8 pence, representing a 21% premium to the closing price of 35.4 pence per share on January 27. The transaction, structured ...

Rocket Lab surged 188% in 2025, reaching a $44B market cap, but current economics do not justify this valuation. Electron rocket launches generate ~$3M gross profit per flight, far below the scale ...

Goldman Sachs, initiating coverage with a Neutral rating, highlighted that over 85% of Healthpeak’s net operating income now comes from outpatient medical and lab space following the 2024 merger with ...

Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

“Bridging The Swarm” was Rocket Lab’s second mission of 2026 and 81 st launch overall. Upcoming launches in 2026 include missions for commercial Earth observation, international space agencies, ...

Shares of Gilead Sciences Inc. rose 3.65% to $135.93 Friday, on what proved to be an all-around mixed trading session for the ...